Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: A multicenter prospective observational study

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 2, 2014, Pages 266-272

  Lipsky, B A ^a   Napolitano, L M ^b   Moran, G J ^c   Vo, L ^d   Nicholson, S ^d   Chen, S ^e   Boulanger, L ^e   Kim, M ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Complicated skin and soft tissue infections; Economic outcomes; Inappropriate antibiotics treatment

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; LINCOSAMIDE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECONOMIC EVALUATION; EMERGENCY WARD; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE UTILIZATION; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED STATES; AGED; CLINICAL TRIAL; CROSS INFECTION; ECONOMICS; EMERGENCY HEALTH SERVICE; HEALTH CARE COST; INAPPROPRIATE PRESCRIBING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH CARE COSTS; HUMANS; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84900484255     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.02.013     Document Type: Article

References (30)

1. Cheong H.S., Kang C.I., Wi Y.M., Ko K.S., Chung D.R., Lee N.Y., et al. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis 2008, 27:1219-1225.
2. De Rosa F.G., Pagani N., Fossati L., Raviolo S., Cometto C., Cavallerio P., et al. The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection 2011, 39:555-561.
3. Eagye K.J., Kim A., Laohavaleeson S., Kuti J.L., Nicolau D.P. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?. Surg Infect (Larchmt) 2009, 10:323-331.
4. Edelsberg J., Berger A., Weber D.J., Mallick R., Kuznik A., Oster G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008, 29:160-169.
5. Edelsberg J., Taneja C., Zervos M., Haque N., Moore C., Reyes K., et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009, 15:1516-1518.
6. Erbay A., Idil A., Gozel M.G., Mumcuoglu I., Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents 2009, 34:575-579.
7. Greene W.H. Econometric analysis 2003, Pearson Education, Inc., Upper Saddle River, NJ. 5th ed.
8. Hatoum H.T., Akhras K.S., Lin S.J. The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study. Diagn Microbiol Infect Dis 2009, 64:305-310.
9. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
10. Itani K.M., Merchant S., Lin S.J., Akhras K., Alandete J.C., Hatoum H.T. Outcomes and management costs in patients hospitalized for skin and skin-structure infections. Am J Infect Control 2011, 39:42-49.
11. Kang C.I., Chung D.R., Ko K.S., Peck K.R., Song J.H. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli. Scand J Infect Dis 2011, 43:202-208.
12. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
13. Kollef M.H. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008, 47(Suppl 1):S3-S13.
14. Kollef M.H., Sherman G., Ward S., Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
15. Kollef K.E., Schramm G.E., Wills A.R., Reichley R.M., Micek S.T., Kollef M.H. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008, 134:281-287.
16. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
17. Kumar A., Ellis P., Arabi Y., Roberts D., Light B., Parrillo J.E., et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009, 136:1237-1248.
18. Kuti E.L., Patel A.A., Coleman C.I. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care 2008, 23:91-100.
19. Lipsky B.A., Moran G.J., Napolitano L.M., Vo L., Nicholson S., Kim M. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. BMC Infect Dis 2012, 12:227.
20. Mccaig L.F., Mcdonald L.C., Mandal S., Jernigan D.B. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006, 12:1715-1723.
21. Micek S.T., Kollef K.E., Reichley R.M., Roubinian N., Kollef M.H. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007, 51:3568-3573.
22. Micek S.T., Welch E.C., Khan J., Pervez M., Doherty J.A., Reichley R.M., et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010, 54:1742-1748.
23. Micek S.T., Reichley R.M., Kollef M.H. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore) 2011, 90:390-395.
24. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., Mcdougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
25. Nathwani D. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?. J Antimicrob Chemother 2003, 51:ii37-ii44.
26. Schramm G.E., Johnson J.A., Doherty J.A., Micek S.T., Kollef M.H. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 2006, 34:2069-2074.
27. Shorr A.F., Micek S.T., Kollef M.H. Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Crit Care Med 2008, 36:2335-2340.
28. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Goldstein E.J., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406.
29. Teng C.S., Lo W.T., Wang S.R., Tseng M.H., Chu M.L., Wang C.C. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. J Microbiol Immunol Infect 2009, 42:324-328.
30. Zilberberg M.D., Shorr A.F., Micek S.T., Chen J., Ramsey A.M., Hoban A.P., et al. Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med 2010, 5:535-540.